Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
RESynchronisation in Patients with heart failure and a Normal QRS Duration (RESPOND)
ISRCTN ISRCTN17623123
ClinicalTrials.gov identifier NCT00480051
Public title RESynchronisation in Patients with heart failure and a Normal QRS Duration (RESPOND)
Scientific title RESynchronisation in Patients with heart failure and a Normal QRS Duration (RESPOND): A randomised controlled trial
Acronym RESPOND
Serial number at source 07/MRE00/57
Study hypothesis Biventricular pacing in patients with heart failure and Quick Release System (QRS) less than 120 ms will improve patient exercise tolerance.

Please note that as of 19/02/10 the title and acronym of this study has been updated. The study was previously known as:
Title: Birmingham biventricular pacing in patients with heart failure unselected for dyssynchrony
Acronym: BIPIDS (BIventricular Pacing In patients unselected for DysSynchrony)
Ethics approval Ethics approval received from the Scotland A Research Ethics Committee on the 15th June 2007 (ref: 3. 07/MRE00/57).
Study design Randomised open label active controlled parallel group trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cardiac failure
Participants - inclusion criteria 1. Sinus rhythm
2. Symptomatic heart failure - New York Heart Association (NYHA) class III or IV
3. Electrocardiogram (ECG) QRS duration less than 120 milliseconds
4. Left ventricular (LV) ejection fraction of less than 35% on echocardiography using Simpson’s methodology
5. Able to give informed consent
Participants - exclusion criteria 1. Age below 18
2. Current or planned pregnancy
3. Patient refusal
4. Ventricular tachycardia or ventricular fibrillation
5. Current or recent (within last 30 days) involvement in other studies
6. Requires implantable cardioverter defibrillator (ICD)
Anticipated start date 01/07/2007
Anticipated end date 01/07/2009
Status of trial Completed
Patient information material
Target number of participants 60
Interventions The patients will be randomised to the control and intervention groups (50% each). The patients in the intervention group will have the cardiac resynchronisation therapy (CRT) implant.

Please note that as of 19/02/10 data collection and enrollment for this trial has now ended.
Primary outcome measure(s) Improvements in 6-minute walking distance (distance that the patient can walk at their own pace in 6 minutes) assessed at baseline, 6 weeks and 6 months. 20% increase in distance walked in 6 minutes, or any increase from 0 will be taken as a significant endpoint.
Secondary outcome measure(s) 1. Symptomatic improvement in quality of life at baseline, 6 weeks after intervention and 6 monthly thereafter, assessed using the Minnesota Living with Heart Failure questionnaire
2. Change in N-terminal pro-beta natriuretic peptide (NT pro-BNP) and echocardiographic parameters of LV function at baseline, 6 weeks after intervention and 6 monthly thereafter. 15% decrease in end systolic volume will be taken as a significant endpoint
3. Assessing whether magnetic resonance imaging (MRI) Dyssynchrony Index (cardiovascular magnetic resonance tissue synchronisation imaging [CMR-TSI]) predicts responders (at baseline)
4. Packer outcome at 6 weeks after intervention and 6 monthly thereafter
5. Hospitalisation will be monitored at 6 weeks after intervention and 6 monthly thereafter
6. Mortality will be monitored at 6 weeks after intervention and 6 monthly thereafter
Sources of funding Good Hope Hospital NHS Trust (UK) - Cardiology Clinical Research Fund
Trial website
Publications
Contact name Dr  Francisco  Leyva
  Address Cardiology
Good Hope Hospital
Heart of England Foundation NHS Trust
Rectory Road
  City/town Sutton Coldfield
  Zip/Postcode B75 7RR
  Country United Kingdom
Sponsor Heart of England Foundation NHS Trust (UK)
  Address Good Hope Hospital
Rectory Road
  City/town Sutton Coldfield
  Zip/Postcode B75 7RR
  Country United Kingdom
  Tel +44 (0)121 378 2211
  Fax +44 (0)121 311 1074
  Email dawn.richardson@heartofengland.nhs.uk
  Sponsor website: http://www.heartofengland.nhs.uk
Date applied 08/06/2007
Last edited 19/02/2010
Date ISRCTN assigned 12/09/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central